Acid Reducer (ranitidine) Tablet: N-nitrosodimethylamine (ndma) Impurity
Recall Summary Acid Reducer tablets containing ranitidine (75 mg and 150 mg versions) are being recalled across Canada because they contain an impurity called N-nitrosodimethylamine (NDMA). This recall affects all consumers who purchased these products. The recall is classified as Class I, meaning the contamination could cause serious health consequences.
- Product
- Acid Reducer (Ranitidine) 75 mg Tablet; Maximum Strength Acid reducer (Ranitidine) 150 mg Tablet without prescription
- Reason
- Contamination
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-12-03
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/d232bbb2-6b5d-40b9-9918-6ae23fc7377f